Trails Edge Capital Partners »

Aura Biosciences shares owned by Trails Edge Capital Partners

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Trails Edge Capital Partners from 13F filings

Historical chart of Trails Edge Capital Partners investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Trails Edge Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Trails Edge Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 1.4M 7.10

More positions owned by Trails Edge Capital Partners

Lb Pharmaceuticals Com Shs (LBRX)
Nurix Therapeutics (NRIX)
Immunocore Hldgs Ads (IMCR)
First Tracks Biotherapeutics Ord Shs (TRAX)
4d Molecular Therapeutics In (FDMT)
BioMarin Pharmaceutical (BMRN)
Design Therapeutics (DSGN)
Xenon Pharmaceuticals (XENE)
Mirum Pharmaceuticals (MIRM)
Insmed Com Par $.01 (INSM)
Cytokinetics Com New (CYTK)
Syndax Pharmaceuticals (SNDX)
Neurogene (NGNE)
Kailera Therapeutics Common Stock
Revolution Medicines (RVMD)

View all positions for Trails Edge Capital Partners

Top funds holding Aura Biosciences

TCG Crossover Management
Suvretta Capital Management
Frazier Life Sciences Management
Long Focus Capital Management
BlackRock
Adage Capital Partners GP
Caligan Partners
Vanguard Capital Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Medicxi Ventures Management
Nantahala Capital Management
Jupiter Topco
RA Capital Management
Balyasny Asset Management

View all funds holding Aura Biosciences